SPX4,274.04-31.16 -0.72%
DIA340.20-1.54 -0.45%
IXIC12,938.12-164.43 -1.25%

--Needham Adjusts CONMED's Price Target to $127 From $155, Noting Currency Headwinds, Keeps Buy Rating Amid Accelerating Growth

--Needham Adjusts CONMED's Price Target to $127 From $155, Noting Currency Headwinds, Keeps Buy Rating Amid Accelerating Growth

MT Newswires · 07/28/2022 01:53

Please log in to view news